The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

NCT ID: NCT05908019

Last Updated: 2023-06-18

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-05
• Study Completion Date: 2024-12-31

Brief Summary

Pulmonary arterial hypertension (PAH) is a chronic disease characterized by an elevation in pulmonary artery pressures and pulmonary vascular resistance. The condition most often is rarely detected, and patients frequently suffer symptoms for several years before being appropriately diagnosed. Patients with PH suffer from several symptoms, such as exertional dyspnea, fatigue, weakness, chest pain, fainting…et al. Pulmonary hypertension is an incurable and progressive disease with complex symptoms and treatments. Patients must learn to deal with their unpredictable future and manage the complex treatments associated with severe adverse effects and need significant changes in lifestyle.

Therefore, it is important to assist patients to develop the ability of symptom management.

Conditions

Web-based Health Care Program

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

Web-based health care program

We aim to develop a PAH web-based health care program, and to evaluate the effects of this program on ameliorating social support, self-care ability and active tolerance, and improving symptom distress, anxiety, depression and quality of life in patients with PAH.

Group Type: EXPERIMENTAL

Web-based health care program

Intervention Type: OTHER

According to the participants' feedback and recommends, we will modify this program to make it more suitable.

In the second and third years, we will conduct a parallel-group, double blind, and block randomization, experimental design study to examine the effectiveness of the Pulmonary Hypertension Web-Based Care Program on the improvements of patients' social support, self-care ability, active tolerance, symptom distress, depression, anxiety and quality of life in patients with PAH.

Usual care

usual care

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Web-based health care program

According to the participants' feedback and recommends, we will modify this program to make it more suitable.

In the second and third years, we will conduct a parallel-group, double blind, and block randomization, experimental design study to examine the effectiveness of the Pulmonary Hypertension Web-Based Care Program on the improvements of patients' social support, self-care ability, active tolerance, symptom distress, depression, anxiety and quality of life in patients with PAH.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

1. At least 20 years old, diagnosed by clinical specialists as patients with pulmonary hypertension (Group1 and Group 4)

2. Clear consciousness, able to communicate in Mandarin and Taiwanese, with normal hearing

3. Those who have internet or mobile internet at home

4. Adults without mental illness

5. No alcohol or drug abusers.

Exclusion Criteria

1. critical disease

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Defense Medical Center, Taiwan

OTHER

Sponsor Role: lead

Responsible Party

Miao-Yi Chen

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Tri-Service General Hospital

Taipei, Taiwan, Taipei, Taiwan

Site Status: RECRUITING

Countries

Taiwan

Central Contacts

Chen miao-yi, PhD Stusent

Role: CONTACT

miaoyi820@gmail.com

0955762820

Facility Contacts

Chen Miao-Yi, PhD student

Role: primary

miaoyi820@gmail.com

0955762820

Other Identifiers

NDMC

Identifier Type: -

Identifier Source: org_study_id